Company Description
Array BioPharma is discovering it's best to be your own boss. Once devoted to discovering drug candidates for other firms, the company is...
Key Array BioPharma Financials
| Company Type | Public - NASDAQ (GM): ARRY Main Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2008 Sales (mil.) | $28.8 |
| Employees | -- |
More Array BioPharma Financials (11 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Array BioPharma's competition across multiple industries
Top Array BioPharma Competitors
Sponsored Links
The Business Directory
Array BioPharma Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Kyle A. Lefkoff | Network | E-mail |
| CEO and Director | Robert E. (Bob) Conway | Network | E-mail |
| President, Chief Scientific Officer, and Director | Kevin Koch | Network | E-mail |
More Array BioPharma Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Array BioPharma News
- IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS [PCT Biblio Info] (02 Dec 2008 08:43:00 EST)
- NOVEL PEPTIDE INHIBITORS OF HEPATITIS C VIRUS REPLICATION [PCT Biblio Info] (02 Dec 2008 08:28:00 EST)
- Quinazoline analogs as receptor tyrosine kinase inhibitors [U.S. Patents] (02 Dec 2008 08:05:00 EST)
Sponsored Opportunity
